News
- Author:
- Will Pass
Publish date: September 30, 2020
Testing should balance local prevalence, false positives, false negatives, and endoscopist risk tolerance.
News
- Author:
- Will Pass
Publish date: September 15, 2020
While emerging technologies may improve detection rates in the future, short-term progress will depend on human expertise.
News
- Author:
- Will Pass
Publish date: September 14, 2020
Across 22 randomized, controlled trials and observational studies, objective and symptomatic improvement varied between endoscopic modalities.
News
- Author:
- Will Pass
Publish date: September 10, 2020
“It has become increasingly clear that COVID-19 has systemic effects that also includes the gastrointestinal and pancreaticobiliary systems,” the i...
News
- Author:
- Will Pass
Publish date: September 9, 2020
“It has become increasingly clear that COVID-19 has systemic effects that also includes the gastrointestinal and pancreaticobiliary systems,” the i...
News
- Author:
- Will Pass
Publish date: September 2, 2020
Social determinants of health include an array of population factors, including economic stability, social and community context, neighborhood and ...
News
- Author:
- Will Pass
Publish date: September 1, 2020
Creative local solutions are needed to address screening and health care problems.
News
- Author:
- Will Pass
Publish date: September 1, 2020
Endoscopy is central to management of nonvariceal upper GI bleeding, but only after patients are appropriately triaged and stabilized.
News
- Author:
- Will Pass
Publish date: August 14, 2020
The most important recommendation is to optimize the ferritin threshold with a high sensitivity.
News
- Author:
- Will Pass
Publish date: August 5, 2020
Among patients who had dose increases, only 24.7% had objective evidence of active inflammation.
News
- Author:
- Will Pass
Publish date: July 20, 2020
Individuals who received a reminder and a fecal immunochemical testing kit had an estimated 23.3% colorectal cancer screening rate, compared with 1...
News
- Author:
- Will Pass
Publish date: July 16, 2020
Pooled clinical success and rebleeding rates were 92% and 20%, respectively.
News
- Author:
- Will Pass
Publish date: July 10, 2020
BRCA carrier status alone should not influence screening recommendations for colorectal cancer or pancreatic ductal adenocarcinoma.
News
- Author:
- Will Pass
Publish date: July 10, 2020
Few recommendations can be made on the basis of existing evidence.
News
- Author:
- Will Pass
Publish date: July 7, 2020
"We seek to summarize international data on the GI and liver manifestations of COVID-19 infection and treatment," the panelists wrote.
